Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 4
2005 1
2006 3
2007 1
2011 1
2012 2
2014 2
2015 2
2016 1
2017 2
2018 4
2019 4
2020 4
2021 8
2022 7
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R, Grigg A, Torkildsen Ø, Bo L, Lehmann AK, Havrdova EK, Krasulova E, Trnený M, Kozak T, van der Walt A, Butzkueven H, McCombe P, Skibina O, Lechner-Scott J, Willekens B, Cartechini E, Ozakbas S, Alroughani R, Kuhle J, Patti F, Duquette P, Lugaresi A, Khoury SJ, Slee M, Turkoglu R, Hodgkinson S, John N, Maimone D, Sa MJ, van Pesch V, Gerlach O, Laureys G, Van Hijfte L, Karabudak R, Spitaleri D, Csepany T, Gouider R, Castillo-Triviño T, Taylor B, Sharrack B, Snowden JA; MSBase Study Group Collaborators; MSBase Study Group Authors; Mrabet S, Garber J, Sanchez-Menoyo JL, Aguera-Morales E, Blanco Y, Al-Asmi A, Weinstock-Guttman B, Fragoso Y, de Gans K, Kermode A; MSBase Study Group. Kalincik T, et al. Among authors: sutton i. JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/jamaneurol.2023.1184. JAMA Neurol. 2023. PMID: 37437240
Paraneoplastic neurological syndromes.
Sutton I. Sutton I. Curr Opin Neurol. 2002 Dec;15(6):685-90. doi: 10.1097/01.wco.0000044764.39452.64. Curr Opin Neurol. 2002. PMID: 12447106 Review.
Neutropaenia complications from Ocrelizumab and Rituximab treatment.
Pang V, Seery N, Wesselingh R, Yeh W, Zhong M, Tan T, Dwyer C, Nesbitt C, Rath L, Perera D, Bridge F, Skibina O, Bosco JJ, Jokubaitis V, Marriott M, Butkueven H, Van Der Walt A, Massey J, Sutton I, Monif M. Pang V, et al. Among authors: sutton i. Mult Scler Relat Disord. 2024 Jan;81:105147. doi: 10.1016/j.msard.2023.105147. Epub 2023 Nov 21. Mult Scler Relat Disord. 2024. PMID: 38043368 Free article.
Neuromyelitis optica: not a multiple sclerosis variant.
Barnett MH, Sutton I. Barnett MH, et al. Among authors: sutton i. Curr Opin Neurol. 2012 Jun;25(3):215-20. doi: 10.1097/WCO.0b013e3283533a3f. Curr Opin Neurol. 2012. PMID: 22487568 Review.
A treatment algorithm for neuropathic pain.
Namaka M, Gramlich CR, Ruhlen D, Melanson M, Sutton I, Major J. Namaka M, et al. Among authors: sutton i. Clin Ther. 2004 Jul;26(7):951-79. doi: 10.1016/s0149-2918(04)90171-3. Clin Ther. 2004. PMID: 15336464 Review.
The pathology of multiple sclerosis: a paradigm shift.
Barnett MH, Sutton I. Barnett MH, et al. Among authors: sutton i. Curr Opin Neurol. 2006 Jun;19(3):242-7. doi: 10.1097/01.wco.0000227032.47458.cb. Curr Opin Neurol. 2006. PMID: 16702829 Review.
Response to treatment in NMOSD: the Australasian experience.
Clarke L, Bukhari W, O'Gorman CM, Khalilidehkordi E, Arnett S, Woodhall M, Prain KM, Parratt JDE, Barnett MH, Marriott MP, McCombe PA, Sutton I, Boggild M, Brownlee W, Carroll WM, Hodgkinson S, Macdonell RAL, Mason DF, Pereira J, Slee M, Das C, Henderson APD, Kermode AG, Lechner-Scott J; ANZ NMO Collaboration; Waters P, Sun J, Broadley SA. Clarke L, et al. Among authors: sutton i. Mult Scler Relat Disord. 2022 Feb;58:103408. doi: 10.1016/j.msard.2021.103408. Epub 2021 Nov 21. Mult Scler Relat Disord. 2022. PMID: 35216788
47 results